CoChat

Proteomics Research in Cardiovascular Medicine and Biomarker Discovery

Open access
Lam, Maggie P.Y., Ping, Peipei, Murphy, Elizabeth · 2016 · Journal of the American College of Cardiology
Cited by 105

The DOI matches its Crossref record; 19 of the 19 references it cites were found in a registry or an index.

Abstract

Proteomics is a systems physiology discipline to address the large-scale characterization of protein species within a biological system, be it a cell, a tissue, a body biofluid, an organism, or a cohort population. Building on advances from chemical analytical platforms (e.g., mass spectrometry and other technologies), proteomics approaches have contributed powerful applications in cardiovascular biomedicine, most notably in: 1) the discovery of circulating protein biomarkers of heart diseases from plasma samples; and 2) the identification of disease mechanisms and potential therapeutic targets in cardiovascular tissues, in both preclinical models and translational studies. Contemporary proteomics investigations offer powerful means to simultaneously examine tens of thousands of proteins in various samples, and understand their molecular phenotypes in health and disease. This concise review introduces study design considerations, example applications and use cases, as well as interpretation and analysis of proteomics data in cardiovascular biomedicine.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.jacc.2016.10.031

Cites

19 of 19 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 19 references

Research works printed but not linked: 92

  1. McDonough, 2001, Cardiac troponin I is modified in the myocardium of bypass patients, Circulation, 103, 58, 10.1161/01.CIR.103.1.58 · DOI · Paper page
  2. Weekes, 1999, Bovine dilated cardiomyopathy: proteomic analysis of an animal model of human dilated cardiomyopathy, Electrophoresis, 20, 898, 10.1002/(SICI)1522-2683(19990101)20:4/5<898::AID-ELPS898>3.0.CO;2-B · doi:10.1002/(sici)1522-2683(19990101)20:4/5<898::aid-elps898>3.0.co;2-b
  3. Ping, 2001, Functional proteomic analysis of protein kinase C ε signaling complexes in the normal heart and during cardioprotection, Circ Res, 88, 59, 10.1161/01.RES.88.1.59 · DOI · Paper page
  4. Edmondson, 2002, Protein kinase C ε signaling complexes include metabolism- and transcription/translation-related proteins: complimentary separation techniques with LC/MS/MS, Mol Cell Proteomics, 1, 421, 10.1074/mcp.M100036-MCP200 · DOI
  5. Lindsey, 2006, A multidimensional proteomic approach to identify hypertrophy-associated proteins, Proteomics, 6, 2225, 10.1002/pmic.200500013 · doi:10.1002/pmic.200500013
  6. Sun, 2006, Hypercontractile female hearts exhibit increased S-nitrosylation of the L-type Ca2+ channel α1 subunit and reduced ischemia/reperfusion injury, Circ Res, 98, 403, 10.1161/01.RES.0000202707.79018.0a · DOI · Paper page
  7. Larance, 2015, Multidimensional proteomics for cell biology, Nat Rev Mol Cell Biol, 16, 269, 10.1038/nrm3970 · DOI · Paper page
  8. Tian, 2004, Integrated genomic and proteomic analyses of gene expression in mammalian cells, Mol Cell Proteomics, 3, 960, 10.1074/mcp.M400055-MCP200 · DOI · Paper page
  9. Marshall, 2014, Proteomic mapping of proteins released during necrosis and apoptosis from cultured neonatal cardiac myocytes, Am J Physiol Cell Physiol, 306, C639, 10.1152/ajpcell.00167.2013 · DOI
  10. Van Eyk, 2001, Proteomics: unraveling the complexity of heart disease and striving to change cardiology, Curr Opin Mol Ther, 3, 546
  11. Nanjappa, 2014, Plasma Proteome Database as a resource for proteomics research: 2014 update, Nucleic Acids Res, 42, D959, 10.1093/nar/gkt1251 · DOI · Paper page
  12. Pundir, 2015, Searching and navigating UniProt databases, Curr Protoc Bioinformatics, 50, 1.27.1, 10.1002/0471250953.bi0127s50 · DOI
  13. Kusebauch, 2014, Using PeptideAtlas, SRMAtlas, and PASSEL: comprehensive resources for discovery and targeted proteomics, Curr Protoc Bioinformatics, 46, 13.25.1, 10.1002/0471250953.bi1325s46 · DOI · Paper page
  14. Zong, 2013, Integration of cardiac proteome biology and medicine by a specialized knowledgebase, Circ Res, 113, 1043, 10.1161/CIRCRESAHA.113.301151 · DOI
  15. Riley, 2016, Proteomics moves into the fast lane, Cell Syst, 2, 142, 10.1016/j.cels.2016.03.002 · DOI
  16. Bensimon, 2012, Mass spectrometry-based proteomics and network biology, Annu Rev Biochem, 81, 379, 10.1146/annurev-biochem-072909-100424 · DOI · Paper page
  17. Keshishian, 2009, Quantification of cardiovascular biomarkers in patient plasma by targeted mass spectrometry and stable isotope dilution, Mol Cell Proteomics, 8, 2339, 10.1074/mcp.M900140-MCP200 · DOI · Paper page
  18. Lam, 2013, Site-specific quantitative analysis of cardiac mitochondrial protein phosphorylation, J Proteomics, 81, 15, 10.1016/j.jprot.2012.09.015 · DOI
  19. Zhang, 2012, Multiple reaction monitoring to identify site-specific troponin I phosphorylated residues in the failing human heart, Circulation, 126, 1828, 10.1161/CIRCULATIONAHA.112.096388 · DOI · Paper page
  20. Percy, 2015, Precise quantitation of 136 urinary proteins by LC/MRM-MS using stable isotope labeled peptides as internal standards for biomarker discovery and/or verification studies, Methods, 81, 24, 10.1016/j.ymeth.2015.04.001 · DOI
  21. Fu, 2016, Multiple and selective reaction monitoring using triple quadrupole mass spectrometer: preclinical large cohort analysis, Methods Mol Biol, 1410, 249, 10.1007/978-1-4939-3524-6_15 · DOI
  22. Percy, 2013, Targeted quantitation of CVD-linked plasma proteins for biomarker verification and validation, Expert Rev Proteomics, 10, 567, 10.1586/14789450.2013.856763 · DOI
  23. Sajic, 2015, Using data-independent, high-resolution mass spectrometry in protein biomarker research: perspectives and clinical applications, Proteomics Clin Appl, 9, 307, 10.1002/prca.201400117 · DOI · Paper page
  24. Ngo, 2016, Aptamer-based proteomic profiling reveals novel candidate biomarkers and pathways in cardiovascular disease, Circulation, 134, 270, 10.1161/CIRCULATIONAHA.116.021803 · DOI · Paper page
  25. Lind, 2015, Discovery of new risk markers for ischemic stroke using a novel targeted proteomics chip, Stroke, 46, 3340, 10.1161/STROKEAHA.115.010829 · DOI
  26. Sabatine, 2016, Using aptamer-based technology to probe the plasma proteome for cardiovascular disease prediction, JAMA, 315, 2525, 10.1001/jama.2016.6110 · DOI
  27. Gramolini, 2016, Identifying low-abundance biomarkers: aptamer-based proteomics potentially enables more sensitive detection in cardiovascular diseases, Circulation, 134, 286, 10.1161/CIRCULATIONAHA.116.022940 · DOI
  28. Keshishian, 2015, Multiplexed, quantitative workflow for sensitive biomarker discovery in plasma yields novel candidates for early myocardial injury, Mol Cell Proteomics, 14, 2375, 10.1074/mcp.M114.046813 · DOI · Paper page
  29. Cominetti, 2016, Proteomic biomarker discovery in 1000 human plasma samples with mass spectrometry, J Proteome Res, 15, 389, 10.1021/acs.jproteome.5b00901 · DOI · Paper page
  30. Olsen, 2013, Status of large-scale analysis of post-translational modifications by mass spectrometry, Mol Cell Proteomics, 12, 3444, 10.1074/mcp.O113.034181 · DOI · Paper page
  31. Huang, 2016, dbPTM 2016: 10-year anniversary of a resource for post-translational modification of proteins, Nucleic Acids Res, 44, D435, 10.1093/nar/gkv1240 · DOI · Paper page
  32. Thingholm, 2006, Highly selective enrichment of phosphorylated peptides using titanium dioxide, Nat Protoc, 1, 1929, 10.1038/nprot.2006.185 · DOI · Paper page
  33. Lundby, 2013, In vivo phosphoproteomics analysis reveals the cardiac targets of β-adrenergic receptor signaling, Sci Signal, 6, rs11, 10.1126/scisignal.2003506 · DOI · Paper page
  34. Schechter, 2014, Phosphoproteomic profiling of human myocardial tissues distinguishes ischemic from non-ischemic end stage heart failure, PLoS One, 9, e104157, 10.1371/journal.pone.0104157 · DOI
  35. Karamanlidis, 2013, Mitochondrial complex I deficiency increases protein acetylation and accelerates heart failure, Cell Metab, 18, 239, 10.1016/j.cmet.2013.07.002 · DOI · Paper page
  36. Nguyen, 2013, Cyclophilin D modulates mitochondrial acetylome, Circ Res, 113, 1308, 10.1161/CIRCRESAHA.113.301867 · DOI
  37. Yang, 2015, SUMO proteomics to decipher the SUMO-modified proteome regulated by various diseases, Proteomics, 15, 1181, 10.1002/pmic.201400298 · DOI
  38. Barallobre-Barreiro, 2016, Glycoproteomics reveals decorin peptides with anti-myostatin activity in human atrial fibrillation, Circulation, 134, 817, 10.1161/CIRCULATIONAHA.115.016423 · DOI
  39. Parker, 2011, Quantitative N-linked glycoproteomics of myocardial ischemia and reperfusion injury reveals early remodeling in the extracellular environment, Mol Cell Proteomics, 10, 10.1074/mcp.M110.006833 · DOI
  40. Wang, 2011, Redox regulation of mitochondrial ATP synthase: implications for cardiac resynchronization therapy, Circ Res, 109, 750, 10.1161/CIRCRESAHA.111.246124 · DOI · Paper page
  41. Kohr, 2012, Measurement of S-nitrosylation occupancy in the myocardium with cysteine-reactive tandem mass tags: short communication, Circ Res, 111, 1308, 10.1161/CIRCRESAHA.112.271320 · DOI · Paper page
  42. Zong, 2014, Lysine ubiquitination and acetylation of human cardiac 20S proteasomes, Proteomics Clin Appl, 8, 590, 10.1002/prca.201400029 · DOI
  43. Fert-Bober, 2015, Citrullination of myofilament proteins in heart failure, Cardiovasc Res, 108, 232, 10.1093/cvr/cvv185 · DOI · Paper page
  44. Lindsey, 2015, A novel collagen matricryptin reduces left ventricular dilation post-myocardial infarction by promoting scar formation and angiogenesis, J Am Coll Cardiol, 66, 1364, 10.1016/j.jacc.2015.07.035 · DOI · Paper page
  45. Kerbey, 1976, Biochem J, 154, 327, 10.1042/bj1540327 · DOI · Paper page
  46. Sharma, 2014, Ultradeep human phosphoproteome reveals a distinct regulatory nature of Tyr and Ser/Thr-based signaling, Cell Rep, 8, 1583, 10.1016/j.celrep.2014.07.036 · DOI · Paper page
  47. Lundby, 2012, Quantitative maps of protein phosphorylation sites across 14 different rat organs and tissues, Nat Commun, 3, 876, 10.1038/ncomms1871 · DOI · Paper page
  48. Deng, 2011, Phosphoproteome analysis reveals regulatory sites in major pathways of cardiac mitochondria, Mol Cell Proteomics, 10, 10.1074/mcp.M110.000117 · DOI · Paper page
  49. Scholten, 2013, Phosphoproteomics study based on in vivo inhibition reveals sites of calmodulin-dependent protein kinase II regulation in the heart, J Am Heart Assoc, 2, e000318, 10.1161/JAHA.113.000318 · DOI
  50. Kooij, 2013, Characterization of the cardiac myosin binding protein-C phosphoproteome in healthy and failing human hearts, J Mol Cell Cardiol, 60, 116, 10.1016/j.yjmcc.2013.04.012 · DOI
  51. Svinkina, 2015, Deep, quantitative coverage of the lysine acetylome using novel anti-acetyl-lysine antibodies and an optimized proteomic workflow, Mol Cell Proteomics, 14, 2429, 10.1074/mcp.O114.047555 · DOI · Paper page
  52. Horton, 2016, Mitochondrial protein hyperacetylation in the failing heart, JCI Insight, 2, e84897
  53. Sun, 2016, Additive cardioprotection by pharmacological postconditioning with hydrogen sulfide and nitric oxide donors in mouse heart: S-sulfhydration vs. S-nitrosylation, Cardiovasc Res, 110, 96, 10.1093/cvr/cvw037 · DOI
  54. Sun, 2015, Ischaemic preconditioning preferentially increases protein S-nitrosylation in subsarcolemmal mitochondria, Cardiovasc Res, 106, 227, 10.1093/cvr/cvv044 · DOI
  55. Murray, 2013, Quantification of mitochondrial S-nitrosylation by CysTMT6 switch assay, Methods Mol Biol, 1005, 169, 10.1007/978-1-62703-386-2_14 · DOI
  56. Kim, 2012, Metabolic labeling reveals proteome dynamics of mouse mitochondria, Mol Cell Proteomics, 11, 1586, 10.1074/mcp.M112.021162 · DOI · Paper page
  57. Price, 2012, Measurement of human plasma proteome dynamics with 2H2O and liquid chromatography tandem mass spectrometry, Anal Biochem, 420, 73, 10.1016/j.ab.2011.09.007 · DOI
  58. Lam, 2014, Protein kinetic signatures of the remodeling heart following isoproterenol stimulation, J Clin Invest, 124, 1734, 10.1172/JCI73787 · DOI · Paper page
  59. Lau, 2016, A large dataset of protein dynamics in the mammalian heart proteome, Sci Data, 3, 160015, 10.1038/sdata.2016.15 · DOI · Paper page
  60. Kolwicz, 2011, Glucose metabolism and cardiac hypertrophy, Cardiovasc Res, 90, 194, 10.1093/cvr/cvr071 · DOI · Paper page
  61. Hsu, 1998, Selective deamidation of recombinant human stem cell factor during in vitro aging: isolation and characterization of the aspartyl and isoaspartyl homodimers and heterodimers, Biochemistry, 37, 2251, 10.1021/bi972372z · DOI
  62. Burgers, 2015, A systematic evaluation of protein kinase A-A-kinase anchoring protein interaction motifs, Biochemistry, 54, 11, 10.1021/bi500721a · DOI
  63. Aye, 2012, Reorganized PKA-AKAP associations in the failing human heart, J Mol Cell Cardiol, 52, 511, 10.1016/j.yjmcc.2011.06.003 · DOI
  64. Pankow, 2015, ΔF508 CFTR interactome remodelling promotes rescue of cystic fibrosis, Nature, 528, 510, 10.1038/nature15729 · DOI · Paper page
  65. Morris, 2014, Affinity purification-mass spectrometry and network analysis to understand protein-protein interactions, Nat Protoc, 9, 2539, 10.1038/nprot.2014.164 · DOI · Paper page
  66. Waldron, 2016, The cardiac TBX5 interactome reveals a chromatin remodeling network essential for cardiac septation, Dev Cell, 36, 262, 10.1016/j.devcel.2016.01.009 · DOI · Paper page
  67. Rizzetto, 2015, Qualitative and quantitative protein complex prediction through proteome-wide simulations, PLoS Comput Biol, 11, e1004424, 10.1371/journal.pcbi.1004424 · DOI
  68. Goldfarb, 2014, Spotlite: web application and augmented algorithms for predicting co-complexed proteins from affinity purification–mass spectrometry data, J Proteome Res, 13, 5944, 10.1021/pr5008416 · DOI
  69. Gingras, 2007, Analysis of protein complexes using mass spectrometry, Nat Rev Mol Cell Biol, 8, 645, 10.1038/nrm2208 · DOI · Paper page
  70. Leitner, 2016, Crosslinking and mass spectrometry: an integrated technology to understand the structure and function of molecular machines, Trends Biochem Sci, 41, 20, 10.1016/j.tibs.2015.10.008 · DOI · Paper page
  71. Percy, 2013, Multiplexed MRM-based quantitation of candidate cancer biomarker proteins in undepleted and non-enriched human plasma, Proteomics, 13, 2202, 10.1002/pmic.201200316 · DOI
  72. Goodman, 2016, Aligning statistical and scientific reasoning, Science, 352, 1180, 10.1126/science.aaf5406 · DOI
  73. de Lemos, 2015, Applying a big data approach to biomarker discovery: running before we walk?, Circulation, 132, 2289, 10.1161/CIRCULATIONAHA.115.019648 · DOI
  74. Keshishian, 2015, Multiplexed, quantitative workflow for sensitive biomarker discovery in plasma yields novel candidates for early myocardial injury, Mol Cell Proteomics, 14, 1, 10.1074/mcp.M114.046813 · DOI · Paper page
  75. Yin, 2014, Protein biomarkers of new-onset cardiovascular disease: prospective study from the systems approach to biomarker research in cardiovascular disease initiative, Arterioscler Thromb Vasc Biol, 34, 939, 10.1161/ATVBAHA.113.302918 · DOI
  76. Addona, 2011, A pipeline that integrates the discovery and verification of plasma protein biomarkers reveals candidate markers for cardiovascular disease, Nat Biotechnol, 29, 635, 10.1038/nbt.1899 · DOI · Paper page
  77. Kong, 2010, Heart failure-associated changes in RNA splicing of sarcomere genes, Circ Cardiovasc Genet, 3, 138, 10.1161/CIRCGENETICS.109.904698 · DOI · Paper page
  78. Song, 2012, Deep RNA sequencing reveals novel cardiac transcriptomic signatures for physiological and pathological hypertrophy, PLoS One, 7, e35552, 10.1371/journal.pone.0035552 · DOI · Paper page
  79. Hebert, 2013, Neutron-encoded mass signatures for multiplexed proteome quantification, Nat Methods, 10, 332, 10.1038/nmeth.2378 · DOI · Paper page
  80. Stubbs, 1998, Lipoprotein(a) as a risk predictor for cardiac mortality in patients with acute coronary syndromes, Eur Heart J, 19, 1355, 10.1053/euhj.1998.1043 · DOI
  81. de Lemos, 2003, B-type natriuretic peptide in cardiovascular disease, Lancet, 362, 316, 10.1016/S0140-6736(03)13976-1 · DOI · Paper page
  82. Puleo, 1990, Early diagnosis of acute myocardial infarction based on assay for subforms of creatine kinase-MB, Circulation, 82, 759, 10.1161/01.CIR.82.3.759 · DOI · Paper page
  83. Shlipak, 2005, Cystatin C and the risk of death and cardiovascular events among elderly persons, N Engl J Med, 352, 2049, 10.1056/NEJMoa043161 · DOI · Paper page
  84. Daniels, 2008, Lipoprotein-associated phospholipase A2 is an independent predictor of incident coronary heart disease in an apparently healthy older population: the Rancho Bernardo Study, J Am Coll Cardiol, 51, 913, 10.1016/j.jacc.2007.10.048 · DOI
  85. Brennan, 2003, Prognostic value of myeloperoxidase in patients with chest pain, N Engl J Med, 349, 1595, 10.1056/NEJMoa035003 · DOI · Paper page
  86. Kavsak, 2007, Effects of contemporary troponin assay sensitivity on the utility of the early markers myoglobin and CKMB isoforms in evaluating patients with possible acute myocardial infarction, Clin Chim Acta, 380, 213, 10.1016/j.cca.2007.01.001 · DOI
  87. Johnson, 2004, Serum amyloid A as a predictor of coronary artery disease and cardiovascular outcome in women: the National Heart, Lung, and Blood Institute-Sponsored Women's Ischemia Syndrome Evaluation (WISE), Circulation, 109, 726, 10.1161/01.CIR.0000115516.54550.B1 · DOI · Paper page
  88. Adams, 1993, Cardiac troponin I. A marker with high specificity for cardiac injury, Circulation, 88, 101, 10.1161/01.CIR.88.1.101 · DOI · Paper page
  89. Reichlin, 2009, Early diagnosis of myocardial infarction with sensitive cardiac troponin assays, N Engl J Med, 361, 858, 10.1056/NEJMoa0900428 · DOI · Paper page
  90. Danese, 2016, An historical approach to the diagnostic biomarkers of acute coronary syndrome, Ann Transl Med, 4, 194, 10.21037/atm.2016.05.19 · DOI · Paper page
  91. Ladenson, 2007, A personal history of markers of myocyte injury [myocardial infarction], Clin Chim Acta, 381, 3, 10.1016/j.cca.2007.02.039 · DOI
  92. Eng, 1994, An approach to correlate tandem mass spectral data of peptides with amino acid sequences in a protein database, J Am Soc Mass Spectrom, 5, 976, 10.1016/1044-0305(94)80016-2 · DOI · Paper page

Cited by

Metadata

Authors
Lam, M. P. Y., Ping, P., & Murphy, E.
Venue
Journal of the American College of Cardiology
Publisher
Elsevier BV
Published
2016-12
Volume
68
Issue
25
Pages
2819-2830
ISSN
0735-1097 (ISSN-L)
OpenAlex
W2563609186
Cited by
105
References
19
FWCI
2.69
Type
journal article
Language
en
Open access
bronze
Licence

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.